PHAT vs VRTX: Which Stock is Better?
Side-by-side comparison of Phathom Pharmaceuticals Inc and Vertex Pharmaceuticals Inc in 2026
PHAT
Phathom Pharmaceuticals Inc
—
VRTX
Vertex Pharmaceuticals Inc
$498.43
Key Metrics Comparison
| Metric | PHAT | VRTX | Winner |
|---|---|---|---|
| Market Cap | $622.74M | $106.87B | VRTX |
| P/E Ratio | N/A | 29.67 | VRTX |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PHAT
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAT or VRTX a better investment?
Comparing PHAT and VRTX: Phathom Pharmaceuticals Inc has a market cap of $622.74M while Vertex Pharmaceuticals Inc has $106.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAT and VRTX?
PHAT (Phathom Pharmaceuticals Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAT or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHAT or VRTX?
Both PHAT and VRTX show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PHAT or VRTX?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PHAT or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $106.87B compared to $622.74M for PHAT.
Should I buy PHAT or VRTX in 2026?
Both PHAT and VRTX have investment merit. PHAT trades at $N/A while VRTX trades at $498.43. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAT and VRTX stock?
Key differences: Market Cap ($622.74M vs $106.87B), P/E Ratio (N/A vs 29.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PHAT or VRTX in 2026?
The choice between PHAT and VRTX depends on your investment goals. VRTX shows higher revenue growth (0.0%). VRTX has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PHAT and VRTX?
PHAT (Phathom Pharmaceuticals Inc) has a market cap of $622.74M, while VRTX (Vertex Pharmaceuticals Inc) has a market cap of $106.87B. VRTX is the larger company by market value.